A deeper investigation of copy number data in tumor tissue samples from GBM patients in TCGA and the general, healthy population in DECIPHER disproved our initial hypothesis that ERBB4 may be acting as a tumor suppressor in GBM. This evidence concerns the gene ERBB4 and glioblastoma.